- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01246934
Segment Transport Versus Acute Shortening In The Treatment of Tibial Pseudarthroses With Bone Loss
November 23, 2010 updated by: Bezmialem Vakif University
In this study the investigators are presenting the advantages as well as the disadvantages of ACUTE SHORTENING AND RELENGTHENINIG VS SEGMENT TRANSPORT methods.
Study Overview
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34290
- Cengiz Sen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 50 years (Child, Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:TIBIA PSEUDOARTHROSES -
Exclusion Criteria:BONE LOSS GREATER THAN 10 CM
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: COMPLICATION
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
TREATMENT PERIOD AND COMPLICATION RATE
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Paley D, Sen C, Tetsworth K. Acute Shortening With Subsequent Relengthening Versus Bone Transport In The Treatment Of Tibial Bone Defect, 11th Asami North America Annual Scientific Meeting, February 18-25, Berkeley Ca, 2001
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2009
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
February 1, 2010
Study Registration Dates
First Submitted
November 23, 2010
First Submitted That Met QC Criteria
November 23, 2010
First Posted (Estimate)
November 24, 2010
Study Record Updates
Last Update Posted (Estimate)
November 24, 2010
Last Update Submitted That Met QC Criteria
November 23, 2010
Last Verified
November 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BVUORT001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on TIBIA PSEUDOARTHROSES
-
Saglik Bilimleri UniversitesiCompletedNonunion of Fracture of Tibia | Tibia Distal FractureTurkey
-
University Hospital TuebingenPhilip Morris Products S.A.RecruitingSmoking | Tibia FractureGermany
-
University of California, San FranciscoNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedOpen Tibia FractureTanzania
-
Technical University of MunichCompletedTibia Plateau Fracture
-
University of ManitobaOrthopedic Research and Education Foundation; Orthopedic Trauma AssociationTerminatedProximal Tibia FractureCanada
-
AO Clinical Investigation and Publishing DocumentationOssacur Inc.Terminated
-
AO Innovation Translation CenterBerufsgenossenschaftlichen Unfallklinik TuebingenTerminated
-
Aga Khan UniversityCompleted
-
University of WashingtonTerminated
-
King Abdullah International Medical Research CenterUnknown
Clinical Trials on ASR METHOD
-
DePuy OrthopaedicsCompletedTotal Hip Arthroplasty | Adverse Local Tissue ReactionUnited States
-
DePuy InternationalTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Nonunion of Femoral FracturesAustria, Czech Republic, Finland, Germany, Norway, Portugal, Switzerland, United Kingdom
-
Frederiksberg University HospitalCompleted
-
DePuy InternationalTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Nonunion of Femoral FracturesAustralia, Germany, United Kingdom
-
DePuy InternationalTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Nonunion of Femoral FracturesSouth Africa
-
Frederiksberg University HospitalCompletedPatients Suitable for THADenmark
-
Janssen Research & Development, LLCCompletedHealthy | Asthma | Dermatitis, AtopicGermany, Belgium
-
Erasmus Medical CenterJohnson & JohnsonCompleted
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseUnited States
-
Dartmouth-Hitchcock Medical CenterVanderbilt University; University of VermontCompleted